Hangzhou
Hangzhou
Hangzhou, Zhejiang / 浙江, China2 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety and Efficacy of Second Infusion of FAP iCDC in End-stage Dilated Cardiomyopathy | Cardiomegaly, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, cardiomyopathy, cardiovascular disorder, dilated cardiomyopathy, heart disorder, heart failure, hereditary disease, laminopathy | Recruiting | Phase 1 | 2026-07-02 | NCT07516288 | |
| Safety and Efficacy of FAP iCDC in Ischemic Cardiomyopathy | Cell Therapy; Ischemic Cardiomyopathy | Recruiting | Phase 1 | 2026-07-02 | NCT07505199 |